anti-CD38 monoclonal antibody
1 abstract
Abstract
Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies.Org: Memorial Sloan Kettering Cancer Center, MSKCC, Myeloma Service, Department of Medicine, Icahn School of Medicine at Mount Sinai, Adult Bone Marrow Transplant Service,